COMMUNIQUÉS West-GlobeNewswire

Transactions in relation to share buyback program
09/10/2018
Acting under its share buyback authorization, the GN Store Nord Board of Directors initiated a share buyback program on May 2, 2018, in accordance with article 5 of the regulation (EU) no. 596/2014 of 16 April 2014 on [...]
A second abstract accepted at ISOBM in Hamburg demonstrating enhanced diagnostic value when using AroCell’s proprietary sample preparation method
09/10/2018
AroCell AB announces today that a second abstract has been accepted by ISOBM ( International Society of Oncology and BioMarkers) for poster presentation at the annual meeting in Hamburg, Germany November 24-27, 2018. [...]
CellaVision AB pesents the third quarter 2018 on October 23 at 11:00 CET
09/10/2018
CellaVision presents the third quarter 2018 on October 23 at 11:00 CET The information was submitted to the public on October 9, 2018 at 8:20 CET CellaVision AB (publ) will publish the interim report for the third [...]
Eurobio Scientific : 2018 MID-YEAR RESULTS
09/10/2018
2018 MID-YEAR RESULTS Significantly positive EBITDA at +€2.4M A first time in the Group History, thanks to the strategy implemented mid 2017 Paris, October 9, 2018 - 8.00 pm Eurobio Scientific (FR0013240934, ALERS, [...]
Eurobio Scientific : RESULTATS SEMESTRIELS 2018
09/10/2018
RESULTATS SEMESTRIELS 2018 EBITDA significativement positif à +2,4 M€ Une première dans l'histoire du Groupe, fruit de la stratégie mise en place mi 2017 Paris, le 9 octobre 2018 - 8h00 Eurobio Scientific (FR0013240934 [...]
Biocartis Group NV: DISCLOSURE OF OUTSTANDING VOTING SECURITIES
09/10/2018
PRESS RELEASE : REGULATED INFORMATION 9 October 2018, 07:00 CEST Disclosure of Outstanding Voting Securities Mechelen, Belgium, 9 October 2018 - Biocartis Group NV (the 'Company' or 'Biocartis'), an innovative molecular [...]
argenx awarded €2.6 million VLAIO grant to explore new applications of ABDEG technology
09/10/2018
October 9, 2018 Breda, the Netherlands / Ghent, Belgium – argenx (Euronext & Nasdaq: ARGX) a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the [...]
CytomX Therapeutics Announces Presentations at 2018 ESMO Annual Meeting
09/10/2018
Update from PROCLAIM-CX-072 trial of a PD-L1 Probody therapeutic as a monotherapy and in combination with ipilimumab SOUTH SAN FRANCISCO, Calif., Oct. 08, 2018 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq:CTMX [...]
Genmab and Seattle Genetics Announce Tisotumab Vedotin Data to be Presented at ESMO 2018 Congress
09/10/2018
Media Release Data presented from updated analysis of full innovaTV 201 expansion cohort in recurrent or metastatic cervical cancer Copenhagen, Denmark and BOTHELL, Wash., October 9, 2018 – Genmab A/S (Nasdaq Copenhagen [...]
Data Updates from Ongoing MAGE-A10 Studies and MAGE-A4 Study to be presented at the European Society for Medical Oncology (ESMO) 2018 Congress
09/10/2018
PHILADELPHIA and OXFORD, United Kingdom, Oct. 08, 2018 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (“Adaptimmune”) (Nasdaq: ADAP), a leader in T-cell therapy to treat cancer, today announced further details about [...]
BeiGene to Present Clinical Data on Zanubrutinib and Pamiparib at Upcoming Medical Meetings
09/10/2018
CAMBRIDGE, Mass. and BEIJING, China, Oct. 08, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative [...]
Affimed Places AFM11 (CD19/CD3-Targeting T cell Engager) Phase 1 Program on Clinical Hold
08/10/2018
Heidelberg, Germany, October 8, 2018 - Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies that harness the power of [...]
Ossur Hf : Össur hf. initiates a new share buyback program
08/10/2018
Announcement from Össur hf. No. 59/2018 Reykjavík, 8 October 2018 Össur hf. initiates a new share buyback program Össur hf. has decided to initiate a new share buyback program (the "Program") tomorrow, 9 October 2018, [...]
Sanofi: Disclosure of trading in own shares
08/10/2018
Attachment Reporting EN.pdf
Sanofi : Déclaration des transactions sur actions propres
08/10/2018
Pièce jointe Reporting FR.pdf
Ossur Hf : Share buyback program completed
08/10/2018
Announcement from Össur hf. No. 58/2018 Reykjavík, 8 October 2018 Share buyback program completed On 6 March 2018, Össur hf. initiated a share buy-back program, see Company announcement no. 16/2018. The purpose of the [...]
Novitium Pharma Launches Prazosin Hydrochloride Capsules USP
08/10/2018
EAST WINDSOR, N.J., Oct. 08, 2018 (GLOBE NEWSWIRE) -- Novitium Pharma LLC today announced that it has received U.S. Food and Drug Administration approval on its Abbreviated New Drug Application (“ANDA”) for Prazosin [...]
Houston MRI® & Diagnostic Imaging Selects eRAD RIS and Portals
08/10/2018
Medical Imaging Company harnesses innovative technology to execute business strategy GREENVILLE, S.C., Oct. 08, 2018 (GLOBE NEWSWIRE) -- eRAD announced today that Houston MRI® & Diagnostic Imaging, a multi-site, [...]
ABILITY Network Announces the 2018 HomeCare Elite
08/10/2018
Annual Ranking Recognizes Top U.S. Home Health Agencies MINNEAPOLIS, Oct. 08, 2018 (GLOBE NEWSWIRE) -- ABILITY Network, an Inovalon company (Nasdaq; INOV), is pleased to announce the winners of the 2018 HomeCare Elite [...]

Pages